CA Stock MarketDetailed Quotes
APS Aptose Biosciences Inc
- 0.260
- -0.015-5.45%
15min DelayMarket Closed Dec 13 16:00 ET
15.48MMarket Cap-0.07P/E (TTM)
0.280High0.260Low12.55KVolume0.275Open0.275Pre Close3.31KTurnover3.48052wk High0.02%Turnover Ratio59.52MShares0.19052wk Low-3.949EPS TTM14.65MFloat Cap47520.000Historical HighLossP/E (Static)56.33MShs Float0.190Historical Low-10.048EPS LYR7.27%Amplitude--Dividend TTM-1.19P/B1Lot Size--Div YieldTTM
About Aptose Biosciences Inc Company
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.
Company Profile
SymbolAPS
Company NameAptose Biosciences Inc
Founded2006
MarketTSE
Employees36
Fiscal Year Ends12-31
Address251 Consumers Road Suite 1105
CityToronto
CountryCAN
Zip CodeM2J 4R3
Phone+1 647 479-9828
Websitehttps://www.aptose.com
Company Executives
- Name
- Position
- Salary
- Dr. William G. Rice, PhD
- President, Chief Executive Officer and Chairman of the Board
- 924.67K
- Fletcher Payne
- Principal Accounting Officer, Senior Vice President, Chief Financial Officer, Corporate Secretary and Chief Business Officer
- 611.37K
- Dr. Rafael Bejar, M.D.,PhD
- Senior Vice President and Chief Medical Officer
- 750.08K
- Warren Whitehead
- Independent Director
- 122.68K
- Dr. Denis R. Burger,PhD
- Lead Independent Director
- 172.17K
- Dr. Mark D. Vincent, M.D.
- Independent Director
- 127.68K
- Dr. Erich M. Platzer, M.D.,PhD
- Independent Director
- 123.67K
- Carol Gail Ashe
- Independent Director
- 123.67K
- Dr. Bernd R. Seizinger, M.D.,PhD
- Independent Director
- 132.17K
Heat List
CA
Overall
Symbol
Price
% Chg
No Data